In the past decades, Multi-component reactions (MCRs) have been shown to be powerful tools for the synthesis of biologically active compounds and drug candidates from simple and readily accessible starting materials. 1 They offer significant advantages over conventional synthetic strategies by shortening reaction time, reducing waste, saving energy and making full use of starting materials. [2][3][4] Furthermore, the design of MCRs for the development of efficient chemical syntheses of complex and high added value molecules is another attractive area in chemistry. [5][6][7] Naphthoquinone derivatives particularly 3-substituted-2-hydroxy-1,4-naphthoquinones are of much importance because this fragment is a key moiety in numerous biologically active compounds. 8 For example as showed in the figure 1, atovaquone, lapachol, parvaquone and buparvaquone (Figure 1, first row) exhibit antimalarial, antibacterial, antiprotozoal, antitumor activities. 9 Similarly, pyrazolone framework is a well-known heterocycle in many drug substances of medicinal fields. To list some pyrazolone derivatives ( figure 1, seond row) such as antipyrine (phenazone), 4-aminopyrine (aminophenazone), metamizol (novalgin), and 4-isopropylpyrine (propyphenazone) are all useful antipyretic and analgesic drugs. 10 Pyrazolone derivatives also have ubiquitous applications in the development of acaricides, dyes, fungicides, herbicides, insecticides, inhibitors and reagents. [11][12][13][14][15][16][17] It is promising that the integration of these two bioactive units into a single molecule may exhibit new or improved pharmacological properties.Considering the above points, and also in continuation of our interest on the synthesis of different kinds of heterocyclic compounds based on MCRs. [18][19][20][21][22][23][24][25] Herein we wish to report MgCl 2 as a low-toxic catalyst for one-pot synthesis of 2-hydroxy-3-((5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)(phenyl)methyl)naphthalene-1,4-dione